Open original FDA record ↗Recall record
- FDA identifier
- Z-1955-2019
- Company in FDA record
- COVIDIEN LLC
- FDA record creation date
- Jul 9, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The priming volume values printed on the MAHURKA and Argyle acute catheters and Instructions for Use (IFU) are higher than the volumes required to fill each lumen.
Source facts
- Action
- On April 29, 2019, consignees were notified by letter via Federal Express and/or federal mail. The Field Safety Alert informed customers that the priming volume values printed on the MAHURKAR and Argyle acute catheters and Instructions for Use are higher than the volumes required to fill each lumen. The firm will update the IFU for the affected products to provide clarity on the printed priming volumes. In the meantime, the firm recommends the use of a non-heparinized lock solution, such as 4% sodium citrate or 1000 U/mL heparin to mitigate potential risk associated with unintended administration of additional concentrated heparin. The firm asks that customers complete and return the acknowledgement form accompanying the notification even if they do not have affected inventory. If you have experienced quality problems or adverse events, you may contact the firm at quality.assurance@covidien.com.
- Initiated
- 2019-04-29
- Root cause
- Error in labeling
- Terminated
- 2024-01-09
- Distribution
- Nationwide domestic distribution. Foreign distribution to Canada, Australia, New Zealand, Latin America, and Hong Kong.
- Recall number
- Z-1955-2019
- Recall status
- Terminated
- CDRH record ID
- 172734
- FDA record created
- 2019-07-09
- Recall event number
- 82802